Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.7767 -0.0181 (-2.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,110,741
Open 0.7800
Bid (Size) 0.8000 (1,000)
Ask (Size) 0.8160 (9,400)
Prev. Close 0.7948
Today's Range 0.7324 - 0.8475
52wk Range 0.1611 - 3.390
Shares Outstanding 53,887,233
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Discover the most active stocks in Thursday's session. ↗
Via Chartmill

Performance

YTD
+17.7%
+17.7%
1 Month
+235.1%
+235.1%
3 Month
+87.6%
+87.6%
6 Month
-62.1%
-62.1%
1 Year
-58.5%
-58.5%

More News

Read More
Most active stocks in Tuesday's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Discover the most active stocks in Friday's session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-02: top gainers and losers in today's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Outlook Therapeutics Tanks Over 60% On Another FDA Blow – Here’s How Retail Is Reacting ↗
Via Stocktwits
Topics Workforce
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is Outlook Therapeutics, Inc. - Common Stock publicly traded?
Yes, Outlook Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Outlook Therapeutics, Inc. - Common Stock trade on?
Outlook Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Outlook Therapeutics, Inc. - Common Stock?
The ticker symbol for Outlook Therapeutics, Inc. - Common Stock is OTLK on the Nasdaq Stock Market
What is the current price of Outlook Therapeutics, Inc. - Common Stock?
The current price of Outlook Therapeutics, Inc. - Common Stock is 0.7767
When was Outlook Therapeutics, Inc. - Common Stock last traded?
The last trade of Outlook Therapeutics, Inc. - Common Stock was at 06/05/26 04:00 PM ET
What is the market capitalization of Outlook Therapeutics, Inc. - Common Stock?
The market capitalization of Outlook Therapeutics, Inc. - Common Stock is 41.85M
How many shares of Outlook Therapeutics, Inc. - Common Stock are outstanding?
Outlook Therapeutics, Inc. - Common Stock has 42M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.